baber/WOPTO huggingface dataset:
Patent BR-PI0812956-B1 (BR)
Title: Aparelho de tratamento térmico por indução de uma peça de trabalho contínua ou discreta, e, método de tratamento térmico por indução de uma peça de trabalho contínua ou discreta
Inventor: KUNO WEISS
IPC: H05B6/04
Filed: 2008-06-09
Abstract: aparelho de tratamento térmico por indução de uma peça de trabalho contínua ou discreta, e, método de tratamento térmico por indução de uma peça de trabalho contínua ou discreta são providos um aparelho e um processo de aquecimento por indução de uma peça de trabalho (14). a peça de trabalho (14) é movida através de um indutor (12) para tratar termicamente por indução a peça de trabalho (14) com potência elétrica de frequência variável e ciclo de serviço ou controle de amplitude para controlar a magnitude de potência elétrica à medida que a frequência varia. alternativamente a peça de trabalho (14) pode ser estacionária e o indutor (12) pode ser movido ao longo da peça de trabalho (14), ou movimento combinado e coordenado da peça de trabalho (14) e indutor (12) pode ser usado.
Patent BR-PI0820644-B1 (BR)
Title: Método de preparação de uma composição, e, composição
Inventor: THOMAS EHLIS
IPC: A61Q17/04
Filed: 2008-11-20
Abstract: método de preparação de uma composição, e, composição método para preparar uma composição, que compreende (a) um absorvedor a moagem do absorvedor de uv orgânico insolúvel micronizado, cujo método compreende a moagem do absorvedor de uv orgânico insolúvel, em forma de partículas grossas, em um aparelho de moagem, na presença de um auxiliar de moagem selecionado a partir dos grupos:  (b1)ácidos carboxílicos e os seus sais;  (b2)ésteres de ácido graxo;  (b3)alquil fosfatos ou ésteres de ácido fosfórico;  (b4)ácidos carboxílicos etoxilados ou ésteres de polietileno glicol (peg);  (b5)éteres de álcool graxo polietileno glicol (peg) de alcoóis graxos;  (b6)éteres de polietileno/ polipropileno- glicol de graxos c4-28 insaturados;   (b7)alquilfenóis etoxilados ou éteres de alquilfenila etoxilados;  (b8)ésteres de poliol e mono-, di- ou tri-glicerídeos;  (b9)ésteres de ácidos graxos e sacarose;  (b10)mono- e di-ésteres de sorbitano de ácidos graxos c6-c22 saturados e/ ou insaturados e grupos de óxido de etileno; e  (b11)tensoativos, que atuam principalmente como agentes de limpeza ou detergentes.
Patent BR-PI0904859-B1 (BR)
Title: sistema de sensoriamento de posição de conjunto roda/pneu sobressalente para veículo automotor
Inventor: ALEX POZENATO CAMPANHARO
IPC: B60B7/16
Filed: 2009-12-08
Abstract: SISTEMA DE SENSORIAMENTO DE POSIÇÃO DE CONJUNTO RODA/PNEU SOBRESSALENTE PARA VEÍCULO AUTOMOTOR. A presente invenção refere-se a um sistema de sensoriamento de posição de conjunto roda/pneu sobressalente para veículo automotor, capaz de monitorar a movimentação/remoção da roda sobressalente (estepe) de sua cavidade de acomodação, informando o condutor do veículo acerca de um eventual furto da peça, quer seja por uma indicação visual quer seja por meio de um sinal sonoro.
Patent BR-PI0905814-B1 (BR)
Title: Equipamento e processos para a extração de dióxido de carbono gasoso da atmosfera
Inventor: DOMENICO CAPULLI
IPC: B01D53/84
Filed: 2009-04-22
Abstract: processo e equipamento derivado para extração de dióxido de carbono gasoso da atmosfera, por reação química ou biológica, em unidade dinâmica de centrifugação multiventuri para sistemas de ventilação e climatização de ambientes internos ou emissões atmosfcriças de procesos fabris e de geração de energia. a presente patente de invenção se refere a um processamento bifásico gás-líquido empregando a centrifugação e subdivisão com objetivo de solubilizar, aumentar a superfície de contato e reagir por rota química ou biológica o dióxido de carbono contido numa mistura gasosa de forma a transforma-lo em um produto sólido ou incorporado a estrutura celular de micoorganismos, realizando em equipamento com rotor de centrifugação muítiventuri que propicia efetiva transferência reacional entre os gases poluentes, especificamente o dióxido de carbono, contido em emissões de chaminés de processos fabris e centrais térmicas de geração de energia ou no fluxo de retorno de sistemas de ventilação e/ou climatização para efeitos de conforto em ambientes internos como shoppings, hotéis, centros de convenções, centrais de atendimento ("call centers"), hospitais, ar de processos industriais, e um líquido quimicamente ou biologicamente reativo, garantindo a qualidade do ar interno a custas menores de energia pela redução da carga térmica e da menor taxa da tomada de ar externo (t.a.e.), além do contínuo e efetivo controle de poluentes contidos na atmosfera em recirculação minimizando sua ação poluente na atmosfera, o conhecido efeito estufa ou na qualidade do ar de interiores em ambientes climatizados com elevada densidade ocupacional. este processo materializa-se através de equipamento auto-aspirante capaz de centrifugar uma corrente gasosa rica em dióxido de carbono com um líquido, como solução de hidróxido de cálcio ou solução biologicamente ativa como com bactérias aeróbicas não patogênicas, fixando o díóxido de carbono (co~2~) como um sólido de forma a inibir sua ação danosa a atmosfera do planeta que é o de impedir o retorno dos raios solares refletidos para o espaço e provocando o dito efeito estufa, responsável pelo aquecimento global do planeta.
Patent BR-PI0907379-B1 (BR)
Title: Método para controlar um alarme em um instrumento ou sistema médico, e instrumento ou sistema médico para detectar um parâmetro fisiológico e para controlar um alarme
Inventor: DIETER WOHRLE
IPC: A61N1/00
Filed: 2009-01-19
Abstract: método para controlar um alarme em um instrumento ou sistema médico, e, instrumento ou sistema médico para detectar um parâmetro fisiológico e para controlar um alarme a invenção diz respeito a um método para controlar um alarme em um instrumento ou sistema médico, para detectar pelo menos um parâmetro fisiológico de um paciente. o valor atual do parâmetro é detectado consecutivamente e um retardo do alarme é determinado em função de pelo menos um valor detectado do parâmetro fisiológico, e a função produz um retardo de alarme mais curto para valores crescentes de desvio de um valor normal e a um retardo de alarme mais longo para valores decrescentes de desvio de um valor normal. além disto, a duração do valor do parâmetro fisiológico ultrapassa, ou permanece abaixo de, pelo menos um limiar predefinido para um parâmetro fisiológico, definindo, respectivamente, um limite superior ou um limite inferior para a faixa normal do parâmetro fisiológico, (sic) é medido e o alarme é gerado quando a duração do valor determinado do parâmetro fisiológico ultrapassa ou permanece abaixo do limite predefinido de retardo do alarme. este método permite evitar os alarmes incômodos ao mesmo tempo em que também indica de forma confiável, as condições severas de um paciente monitorado.
Patent BR-PI0919203-B1 (BR)
Title: Forno de craqueamento
Inventor: WILLIAM TALLIS
IPC: C07C2/04
Filed: 2009-09-18
Abstract: forno de craqueamento a invenção diz respeito a tubulação para uso como um tubo de pirólise em um forno de craqueamento. o tubo é formado de maneira tal que ele tenha pelo menos uma seção cuja linha de centro curva em três dimensões, para induzir fluxo em turbilhão no tubo. preferivelmente, o tubo é formado como uma hélice.
Patent BR-PI1010566-B1 (BR)
Title: Dispersão de polímero aquosa e composição de multi-componente
Inventor: ANDRÉ PETER
IPC: C04B2/00
Filed: 2010-05-12
Abstract: dispersões aquosas de polímero a presente invenção refere-se à dispersões de polímero aquosas, que, além de água e um copolímero disperso composto de pelo menos dois monômeros selecionados a partir do grupo consistindo em etileno, propileno, butileno, isopreno, butadieno, estireno, acrilonitrila, ácido acrílico, ácido metacrífico, alquil éster de ácido acrílico, alquil éster de ácido metacrílico, vinil éster, e cloreto de vinil, também compreende um polímero de estrutura tipo pente tendo cadeias laterais que são ligadas à cadeia principal pelos grupos de éster ou éter. as referidas dispersões de polímero aquosas são particularmente adequadas para uso junto com agentes de ligação hidráulicos e latentemente hidráulicos. as dispersões de polímero aquosas são extremamente eficientes e resultam em um forte aumento nos valores mecânicos e diminuição relevante na porosidade e na propriedade de absorção de água.
Patent EA-003372-B1 (EA)
Title: Pigment concentrate
Inventor: COUPERUS ANJA
IPC: C09B67/20
Filed: 2000-01-21
Abstract: 1. Method for preparing a pigment concentrate suitable for preparing a powder coating, wherein pigment particles are comminuted in the presence of an aqueous binder essentially consisting of a polyester to form a stable paste or suspension, the paste or suspension formed is subjected to a drying treatment, and the pigment concentrate is collected, characterized in that the polyester has a glass transition temperature of at least 60 DEG C and an acid value of at least 60. 2. Method according to claim 1, characterized in that the binder is a saturated polyester. 3. Method according to claim 2, characterized in that the polyester has an acid value of at least 70. 4. Method according to any one of claims 1 to 3, characterized in that a binder having a co-solvent content of 0-5% is used. 5. Method according to any one of claim 1 to 4, characterized in that the pigment particles are comminuted, with the use of a bead mill, to a particle size of less than 15 mu m. 6. Method according to any one of claims 1 to 5, characterized in that the pigment used is an organic pigment, in particular selected from carbon black, phthalocyanine green, phthalocyanine blue, organic red and organic yellow. 7. Pigment concentrate obtained with the method according to any one of claims 1 to 6. 8. Method for forming a powder to be used as a powder coating, by mixing a pigment with a thermoplastic or thermosetting plastic, where applicable a hardener, and one or more additives, by blending, melting, extruding and finely grinding the mixture into a powder, characterized in that the pigment used is a pigment concentrate according to claim 7. 9. Method for coating a substrate with a powder coating by mixing pigment particles with a thermoplastic or thermosetting plastic, where applicable a hardener, and one or more additives, melting and extruding the mixture formed, comminuting the extrudate formed into a powder, applying the powder obtained to a substrate in the form of a thin layer and melting said thin layer to form a thin film, characterized in that the pigment particles used are pigment concentrate particles obtained according to the method according to any one of claims 1 to 6. 10. Method according to any one of claims 1 to 6, 8 or 9, wherein the powder coating is based on polyester or epoxy-polyester resins.
Patent EA-006618-B1 (EA)
Title: Signalling device to make the administering of medical preparations easier
Inventor: DOLL RAINER FRITZ ROBERT
IPC: A61J7/04
Filed: 2003-07-11
Abstract: A signalling device to make the administering of medical preparations easier, especially to signal the set administering time point of medicines, which contains a house, a data input unit placed in the house, a display unit and memory unit as well as a control unit in connection with these and a power supply, the memory unit has a basic storage register and a personal data storage register wherein the memory unit (30) is supplemented with a time data storage register (32), while the control unit (20) is supplemented with a counting part-unit (21) and comparison part-unit (22), furthermore, the control unit (20) is connected to an alarm part-unit (50), the input (22a) of the comparison part-unit (22) is connected to the time data storage register (33) and the counting part-unit (21), and the output (22b) of the comparison part-unit (22) is directly connected to the alarm part-unit (50) or via the control unit (20).
Patent EA-010109-B1 (EA)
Title: Triazolopyrimidine derivatives as glycogen synthase kinase-3 inhibitors
Inventor: FREYNE EDDY JEAN EDGARD
IPC: A61P25/24
Filed: 2004-07-12
Abstract: This invention concerns a compound of formula (I), a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine and a stereochemic ally isomeric form thereof, wherein ring A represents phenyl, pyridyl, pyrimidinyl, pyridazinyl or pyrazinyl; Rrepresents hydrogen; aryl; formyl; Calkylcarbonyl, Calkyl; Calkyloxycarbonyl; Calkyl substituted with formyl, Calkylearbonyl, Calkyloxycarbonyl, Calkylcarbonyloxy; or CalkyloxyCalkylcarbonyl optionally substituted with Calkyloxycarbonyl; X represents a direct bond; -(CH)or -(CH)-X-X-; Rrepresents Ccycloalkyl; phenyl; a 4, 5, 6- or 7-membered monocyclic heterocycle containing at least one heteroatom. selected from O, S or N; benzoxazolyl or a radical of formula (a-1), wherein said Rsubstituent may optionally be substituted; Rrepresents halo; hydroxy; optionally substituted Calkyl; Calkenyl or Calkynyl, each optionally substituted; optionally substituted polyhalo-Calkyl; optionally substituted Calkyloxy; optionally substituted polyhalo-Calkyloxy; Calkylthio; polyhalo-Calkylthio; Calkyloxycarbonyl; Calkylcarbonyloxy; Calkylcarbonyl; polyhalo- Calkylcarbonyl; cyano; carboxyl; aryloxy; arylthio; arylcarbonyl; NRR; C(=O)-NRR; -NR-C(=O)R; -S(=O)-R; -NRS(=O)-R;-NR-S(=O)-R; -S-CN; -NR-CN; Rrepresents hydrogen; halo; hydroxy; optionally substituted Calkyl; Calkenyl or Calkynyl, each optionally substituted; polyhalo-Calkyl; optionally substituted Calkyloxy; polyhalo-Calkyloxy; Calkylthio; polyhalo-Calkylthio Calkyloxycarbonyl; Calkylcarbonyloxy; Calkylcarbonyl; polyhalo-Calkylcarbonyl; nitro; cyano; carboxyl; NRR; C(=O)NRR; NR-C(=O)-NRR; -NR-C(=O)-R; -S(=O)-R; -NR-S(=O)-R; -S-CN; -NR-CN; their use, pharmaceutical compositions comprising them and processes for their preparation.
Patent EA-009022-B1 (EA)
Title: (thio) carbamoyl-cyclohexane derivatives as d3/d2 receptor antagonists
Inventor: AGAINE CSONGOR EVA
IPC: C07D223/04
Filed: 2004-05-21
Abstract: The present invention relates to new Dand Ddopamine receptor subtype preferring ligands of formula (I): wherein Rand Rrepresent independently a substituent selected from hydrogen, alkyl, aryl, cycloalkyl, aroyl, or Rand Rmay form a heterocyclic ring with the adjacent nitrogen atom; X represents an oxygen or sulphur atom; n is an integer of from 1 to 2, and/or geometric isomers and/or stereoisomers and/or diastereomers and/or salts and/or hydrates and/or solvates thereof, to the processes for producing the same, to pharmaceutical compositions containing the same and to their use in therapy and/or prevention of a condition which requires modulation of dopamine receptors.
Patent EA-014136-B1 (EA)
Title: Process to produce portland cement clinker
Inventor: RAMIREZ TOBIAS HOMERO
IPC: C04B7/345
Filed: 2005-07-08
Abstract: A process for producing Portland cement clinker at low temperatures fixing the sulfur produced by burning high sulfur content coke fuel. The invention also describes a Portland cement clinker that includes new additional phases.
Patent EA-010283-B1 (EA)
Title: Immersed burner with regulated flame
Inventor: PALMEIRI BIAGIO
IPC: C03B5/235
Filed: 2006-01-25
Abstract: The invention concerns the melting vitrifiable materials with at least one immersed burner (9) generating a flame within said melted vitrifiable materials, characterized in that at least one gas intake (10) separated from the burner is sufficiently close to said burner (9) to interact with said flame. The separate intake (10) interacts with the flame of the burner (9) to regulate same, thereby reducing risks of melted materials reverting into the burner (9).
Patent EA-019560-B1 (EA)
Title: Method of treating prostrate (variants)
Inventor: BRODIE ANGELA
IPC: C07J43/00
Filed: 2006-03-02
Abstract: The present invention relates to a method of treating prostate, comprising prostate cancer and prostate hyperplasia. According to one of embodiments the method of treating comprises administering to a patient in need thereof an effective amount of a compoundor a pharmaceutically acceptable salt. In another embodiment a method of treating prostrate comprises administering to a patient in need thereof an effective amount of the compound or a pharmaceutically acceptable salt and physiologically acceptable excipient.
Patent EA-017086-B1 (EA)
Title: Human monoclonal antibodies to o8e and use thereof
Inventor: KORMAN ALAN J
IPC: A61P35/00
Filed: 2006-12-08
Abstract: The present disclosure provides isolated monoclonal antibodies, particularly human monoclonal antibodies that specifically bind to O8E with high affinity. Nucleic acid molecules encoding the antibodies of this disclosure, expression vectors, host cells and methods for expressing the antibodies of this disclosure are also provided. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the antibodies of this disclosure are also provided. This disclosure also provides methods for treating cancer.
Patent EA-018008-B1 (EA)
Title: Concertina-wire barrier rapid deployment method
Inventor: PESSACH OFIR
IPC: E04H17/04
Filed: 2009-02-10
Abstract: Methods and devices for loading, deploying, and receiving concertina-wire barriers along paths with varying travel or paths located at a distance to the access track of a transport vehicle. The first method includes loading a concertina-wire coil arrangement directly into carry tines and adjusting the tine tilt during deployment to reflect the changing gradient. An anchored portion of the wire stretches each coil longitudinally into its operative configuration and position as the transport vehicle advances. A second method involves a generally analogous process in order to deploy the barrier at distance from the access route. Retrieval for both methods is accomplished by inserting the carry tines in the space circumscribed by the deployed coils so that as the transport vehicle advances the coil arrangement is removed from its deployment location and pressed together onto the tines thereby being disposed for the next deployment.
Patent EA-016843-B1 (EA)
Title: Rasagiline tannate
Inventor: FRENKEL ANTON
IPC: A01N33/02
Filed: 2007-12-13
Abstract: The subject invention provides rasagiline tannate, compositions and a process for manufacture thereof.
Patent EA-016936-B1 (EA)
Title: Heterophasic propylene copolymer with improved creep behavior
Inventor: ROEGIERS KRISTIEN
IPC: C08F2/34
Filed: 2008-12-18
Abstract: The present invention concerns heterophasic propylene copolymers, comprising a propylene homopolymer (PPH) and an ethylene-propylene rubber (EPR), having a very broad molecular weight distribution, a well-defined total ethylene content and a specific intrinsic viscosities of the ethylene-propylene rubber (EPR). The invention further concerns the process to produce such heterophasic propylene copolymers. The heterophasic propylene copolymers of the present invention are particularly suited for pails, pallets, IBCs and crates. In particular, the heterophasic propylene copolymers of the present invention are characterized by an improved resistance to creep.
Patent EA-018716-B1 (EA)
Title: Novel 4-(tetrazol-5-yl)quinazoline derivatives as anti cancer agents
Inventor: KONAKANCHI DURGA PRASAD
IPC: A61K31/498
Filed: 2008-10-28
Abstract: The invention relates to substituted 4-(tetrazol-5-yl)quinazoline derivatives of the formula-I, or pharmaceutically-acceptable salts thereof, which possess anti-proliferative activity such as anti-cancer activity and are accordingly useful in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of substituted 4-(tetrazol-5-yl)quinazoline derivatives, to pharmaceutical compositions containing the compound and to its use in the manufacture of medicaments for the production of an anti-proliferative effect in a warm-blooded animal such as man.
Patent EA-024599-B1 (EA)
Title: Spine-corrective corset
Inventor: CHUGUNOV VITALY VIKTOROVICH
IPC: A61F5/02
Filed: 2013-03-12
Abstract: The corset disclosed in the invention relates to medical equipment, applied in traumatology, orthopaedics, neurosurgery, neuropathology, and contains frame, adapted for placement along user's back, adjustable pelvic support, placed around user's pelvic area, first fixation means, fitted for fixation of corset to adjustable pelvic support, second fixation means, made with possibility of fixation to frame and fitted for fixation of user's back in pressed against frame position. Frame possesses spring properties and represents staple-shaped element of complex spatial shape, which has opposite elongated branches, located along user's back at the distance excluding their contact with the area of vertebral column, and are connected to each other across user's back by means of bridge-like connecting device. Free ends of staple-shaped element branches are fixed with possibility of mounting linear vertical movements in first fixation means, made with possibility of changing frame position in sagittal plane relative to adjustable pelvic support. The corset is made with possibility of giving physiologically correct position to user's spine and with possibility of bending in sagittal plane, rotation in horizontal plane and inclination in frontal plane.
Patent EA-030461-B1 (EA)
Title: THERAPEUTIC COMPOSITION AND METHOD OF TREATING AN INFLAMMATORY DISORDER, HYPERCHOLESTERINEMIA, HYPERLIPIDEMIA, TYPE 1 AND 2 DIABETES, AMINOACYL-tRNA SYNTHETASE (AARS) POLYPEPTIDE
Inventor: GREENE LESLIE ANN
IPC: A61P35/00
Filed: 2011-07-11
Abstract: The present invention relates to a therapeutic composition for treating an inflammatory disorder, hypercholesterinemia, hyperlipidemia, type 1 and 2 diabetes, metabolic syndrome or vascular diseases; an isolated aminoacyl-tRNA synthetase (AARS) polypeptide; a cellular composition for recombinant production of an aminoacyl-tRNA synthetase (AARS) polypeptide; an expression vector; a method of identifying a compound that specifically binds to an aminoacyl-tRNA synthetase (AARS) polypeptide; a method of treating an inflammatory disorder, hypercholesterinemia, hyperlipidemia, type 1 and 2 diabetes, metabolic syndrome or vascular diseases.
Patent EA-028216-B1 (EA)
Title: Tomm34 peptides and vaccines including the same
Inventor: NAKAMURA YUSUKE
IPC: G01N33/574
Filed: 2011-11-25
Abstract: The present invention provides isolated peptides or the fragments derived from SEQ ID NO: 42, which bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL). The peptides may include one of the above mentioned amino acid sequences with substitution, deletion, or addition of one, two, or several amino acids sequences. The present invention also provides pharmaceutical compositions including these peptides. The peptides of this invention can be used for treating cancer.